Nuveen’s AYTU BioPharma AYTU Stock Holding History

Nuveen’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,807	Closed	-$2.1M	–	3369
2021 Q1	$2.1M	Buy	+13,807	New	+$2.19M	﹤0.01%	2592
2020 Q4	–	Sell	-496	Closed	-$118K	–	3309
2020 Q3	$118K	Sell	496 -554	-53%	-$142K	﹤0.01%	3207
2020 Q2	$298K	Buy	+1,050	New	+$318K	﹤0.01%	3039

Other funds holding AYTU

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Nuveen's AYTU Position: Q2 2021 in Review

Nuveen sold out of AYTU BioPharma (AYTU) in Q2 2021, closing a stake of 13,807 shares — an estimated $2.1M sold.

Nuveen first reported a position in AYTU in Q2 2020 and held it in 3 quarters. The position peaked at $2.1M in Q1 2021. 50 funds tracked by Wall St. Rank hold AYTU as of Q2 2021.

Nuveen reported no remaining AYTU BioPharma position as of Q2 2021 after selling out during the quarter.
Nuveen sold 13,807 AYTU BioPharma shares in Q2 2021, an estimated $2.1M.
Nuveen first reported a position in AYTU BioPharma in Q2 2020 and held it in 3 quarters.
Nuveen's AYTU BioPharma position peaked at $2.1M in Q1 2021.
50 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.